HK's Ally Bridge leads $150m investment in Sorrento Therapeutics

HK's Ally Bridge leads $150m investment in Sorrento Therapeutics

Sorrento Therapeutics at NASDAQ, 2014

Elaine Huang

10 April, 2016

ally bridge groupSorrento TherapeuticsYuhan Corporation

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.